Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Cimpress
CMPR
$2.3B
| $936K | ﹤0.01% |
33,900
-200
| -0.6% | -$5.19K |
|
|
DFSV
2577
Dimensional US Small Cap Value ETF
DFSV
$8.48B
| $934K | ﹤0.01% |
+37,700
| New | +$932K |
|
2578
Nomura Holdings
NMR
$28.7B
| $931K | ﹤0.01% |
248,290
+18,300
| +8% | +$63.2K |
|
2579
NLI Holdings
NL
$315M
| $930K | ﹤0.01% |
136,614
-10,600
| -7% | -$79K |
|
|
NOAH
2580
Noah Holdings
NOAH
$592M
| $927K | ﹤0.01% |
59,800
-700
| -1% | -$10.2K |
|
2581
TAT Technologies
TATT
$542M
| $926K | ﹤0.01% |
174,702
-13,000
| -7% | -$78.9K |
|
2582
Garrett Motion
GTX
$5.41B
| $924K | ﹤0.01% |
121,200
+7,500
| +7% | +$52.7K |
|
2583
Taboola.com
TBLA
$1.09B
| $924K | ﹤0.01% |
300,100
-371,344
| -55% | -$788K |
|
|
QUOT
2584
DELISTED
Quotient Technology Inc
QUOT
| $918K | ﹤0.01% |
+267,500
| New | +$756K |
|
|
AVDX
2585
DELISTED
AvidXchange
AVDX
| $915K | ﹤0.01% |
92,100
-312,000
| -77% | -$2.71M |
|
2586
Compugen
CGEN
$228M
| $912K | ﹤0.01% |
1,273,766
-1,098,882
| -46% | -$959K |
|
|
INN
2587
Summit Hotel Properties
INN
$651M
| $912K | ﹤0.01% |
126,300
-186,232
| -60% | -$1.46M |
|
|
CFB
2588
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $910K | ﹤0.01% |
73,300
+900
| +1% | +$12K |
|
2589
Jones Lang LaSalle
JLL
$17.3B
| $908K | ﹤0.01% |
5,700
-500
| -8% | -$79.7K |
|
2590
Relay Therapeutics
RLAY
$4.35B
| $908K | ﹤0.01% |
+60,800
| New | +$1.16M |
|
2591
Community Bank
CBU
$3.46B
| $907K | ﹤0.01% |
14,403
-64,705
| -82% | -$4.05M |
|
2592
Urban Edge Properties
UE
$2.76B
| $906K | ﹤0.01% |
64,300
-80,400
| -56% | -$1.15M |
|
2593
Peoples Bancorp of North Carolina
PEBK
$239M
| $905K | ﹤0.01% |
27,792
-1,900
| -6% | -$54.1K |
|
2594
Vroom Inc
VRM
$56.8M
| $901K | ﹤0.01% |
11,045
+1,524
| +16% | +$131K |
|
|
UBP
2595
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $898K | ﹤0.01% |
49,300
-4,600
| -9% | -$85.6K |
|
|
CDTX
2596
DELISTED
Cidara Therapeutics
CDTX
| $896K | ﹤0.01% |
59,269
-5,395
| -8% | -$64.4K |
|
|
AFBI
2597
DELISTED
Affinity Bancshares
AFBI
| $894K | ﹤0.01% |
59,204
-5,300
| -8% | -$76.8K |
|
|
EHAB
2598
DELISTED
Enhabit
EHAB
| $891K | ﹤0.01% |
67,700
-6,300
| -9% | -$84K |
|
|
OGI
2599
Organigram Holdings
OGI
$173M
| $891K | ﹤0.01% |
278,291
+43,891
| +19% | +$165K |
|
|
CLPR
2600
Clipper Realty
CLPR
$54M
| $889K | ﹤0.01% |
138,857
-10,300
| -7% | -$72.1K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.